<DOC>
	<DOC>NCT01308476</DOC>
	<brief_summary>6 months open label non-interventional observational study acc to § 4, section 23 and § 67, section 6 German Medicines Act with two parallel groups 1. the SMS group receiving a daily SMS - a reminder to inhale Spiriva® 18 Microgram 2. the control group not receiving a daily SMS reminder</brief_summary>
	<brief_title>SMS Reminder to Assess Adherence</brief_title>
	<detailed_description>Purpose: Study Design: observational</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Inclusion criteria: Chronic obstructive pulmonary disease (COPD) patients requiring longacting bronchodilators according to approved Summary of Product Characteristics (SPC) and guidelines User of mobile phone Exclusion criteria: Patients presenting with the general and specific contraindications listed in the Patient Information Leaflet and the SPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>